News & insights

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.

more about us

Subscribe to our monthly updates and other company news by completing the form below

Full name*

Email*

Company*

I acknowledge that I have read the Privacy Statement.

I allow Huvepharma and its affiliates to send me email communications. You can manage your subscriptions and unsubscribe at any time here.

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click here.

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

United States

Click here to visit the local website or close this popup to stay on the global website.

top

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

News & insights

Aviapp® - Annual Report for Europe 2022

Huvepharma Returns the only FDA-Approved Triple-Sulfa Medication to US Market

Huvepharma Receives FDA Approval for Tilmovet® AC (Tilmicosin Phosphate)

Effect of Different Levels of Phytases on the Growth Performance of Rainbow Trout Oncorhynchus Mykiss

Soychú, Argentina Recommends Aviapp

Tuloxxin® Injection - Application in Cattle

Improved Performance with OptiPhos® Plus

Huvepharma Inc. Introduces New Vaccine to Combat Necrotic Enteritis

OptiPhos® Plus Receives Positive Opinion From EFSA

Use of Monimax® in Turkeys

Monimax® - Efficacy and Performance

global presence

Local support from a global company

about us

Huvepharma®

Change country

Africa

Asia

Europe

North America

Oceania

South America

Change language

Europe

United States

Your browser is out of date!